glucagon has been researched along with Memory Disorders in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hölscher, C; Li, L; Li, Y; Liu, W; Tai, J | 1 |
Goto, N; Kameyama, T; Oka, J; Suzuki, E | 1 |
Kondo, Y; Oka, J; Suzuki, E | 1 |
3 other study(ies) available for glucagon and Memory Disorders
Article | Year |
---|---|
Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Disease Models, Animal; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hippocampus; Memory Disorders; Mice; Mice, Transgenic; Neuroprotective Agents; Plaque, Amyloid; Presenilin-1; Receptors, Gastrointestinal Hormone; Receptors, Glucagon | 2018 |
Endogenous GLP-1 modulates hippocampal activity in beta-amyloid protein-treated rats.
Topics: Amyloid beta-Peptides; Animals; Avoidance Learning; Brain Chemistry; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hippocampus; Immunohistochemistry; Injections, Intraventricular; Lateral Ventricles; Male; Memory Disorders; Peptide Fragments; Protein Precursors; Rats; Rats, Wistar; Receptors, Glucagon | 1999 |
Endogenous GLP-1 is involved in beta-amyloid protein-induced memory impairment and hippocampal neuronal death in rats.
Topics: Amyloid beta-Peptides; Animals; Cell Death; DNA Fragmentation; Drug Combinations; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Hippocampus; Male; Memory; Memory Disorders; Neurons; Peptide Fragments; Protein Precursors; Rats; Rats, Wistar; Receptors, Glucagon | 2000 |